← Back to Search

Diagnostic Device

Clinical for Fatty Liver Disease

N/A
Waitlist Available
Led By Vijay Shah, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years
Verbal and written fluency of the English Language
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the outcome (correlation of liver histology with mr elastogram) will be assessed once, at the time of outpatient biopsy, then again 1 year later with a second biopsy and a second mre. outcomes will be assessed after second biopsy.
Awards & highlights

Study Summary

This trial will use magnetic resonance elastography (MRE) to non-invasively detect various pathological findings in the liver in response to different insults, in order to provide essential diagnostic, prognostic, and treatment information, obviating the need for invasive liver biopsies.

Eligible Conditions
  • Fatty Liver Disease
  • Obesity

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the outcome (correlation of liver histology with mr elastogram) will be assessed once, at the time of outpatient biopsy, then again 1 year later with a second biopsy and a second mre. outcomes will be assessed after second biopsy.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the outcome (correlation of liver histology with mr elastogram) will be assessed once, at the time of outpatient biopsy, then again 1 year later with a second biopsy and a second mre. outcomes will be assessed after second biopsy. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fibrosis

Trial Design

2Treatment groups
Experimental Treatment
Group I: ClinicalExperimental Treatment1 Intervention
Subjects who received abdominal surgery for non-liver related indications (cholecystectomy, pancreatic cyst resection)
Group II: BariatricExperimental Treatment1 Intervention
Obese adult subjects who are scheduled to undergo bariatric surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Magnetic Resolution Elastography (MRE)
2015
N/A
~250

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,191 Previous Clinical Trials
3,758,242 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,348 Previous Clinical Trials
4,314,489 Total Patients Enrolled
Vijay Shah, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
18 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being admitted into this trial?

"According to the clinicaltrials.gov registry, this particular medical trial is not recruiting subjects at this time; it was initially posted on September 1st 2015 and last revised on March 21st 2022. Nevertheless, there are 1291 other trials actively seeking participants currently."

Answered by AI
~26 spots leftby Mar 2025